Nu Holdings Ltd (NU) Stock Price Today
UBS maintains buy on RELX, sees AI fears as overblown with 42% upside potential.
UBS reaffirmed its buy rating on RELX PLC with a 3,600p price target, arguing that concerns over AI and autonomous vehicles have led to an exaggerated drop in the stock price. The bank believes the impact of autonomous vehicles on RELX’s US auto insu...
Energy Transfer faces delays and market pressure but offers a timely buying opportunity amid challenges.
Energy Transfer is experiencing significant delays and challenges with Project Jupiter, including permitting issues and a force majeure notification that have slowed execution. These setbacks, combined with rising long-term bond yields, have pressure...
Home Depot outperforms Lowe's for retirement investors amid housing market freeze
Home Depot and Lowe's stocks have both dropped this year, but Home Depot is the better choice for retirement investors due to stronger demand trends, a safer balance sheet, and a higher dividend yield. While Lowe's trades cheaper and offers higher re...
S&P 500 faces volatility from inflation, Fed tightening, and geopolitical risks, with cautious investor moves underway.
The S&P 500 is expected to experience short-term volatility due to ongoing inflation pressures, Federal Reserve interest rate hikes, and geopolitical tensions, especially related to the Iran conflict. Rising oil and transportation costs alongside hig...
Three medical device giants keep raising dividends with steady demand and strong cash flow.
Abbott Laboratories, Medtronic, and Becton Dickinson, three leading medical device companies, have each increased their dividends recently, continuing long streaks of annual raises—54 years for Abbott, 49 for Medtronic, and consistent growth for Bect...
Bonds offer rare buying opportunity over stocks as S&P 500 nears record highs amid rising rates.
Despite the S&P 500 nearing record highs, bonds have struggled this year due to rising yields, causing challenges for traditional diversification strategies. However, Bank of America highlights bonds as one of the best buying opportunities in two dec...
Medicus Pharma files streamlined Phase 2b/3 trial for prostate cancer drug Teverelix with FDA
Medicus Pharma has submitted a streamlined Phase 2b/3 trial design to the FDA for Teverelix, a long-acting GnRH antagonist targeting advanced prostate cancer patients at increased cardiovascular risk. The new trial design combines dose optimization, ...
10-year Treasury yield nears 2007 peak amid Fed hikes, energy crisis, and rising US debt.
The 10-year US Treasury yield closed at 5.24% on September 28, 2026, just two basis points below its June 2007 peak of 5.26%, driven by expected Federal Reserve rate hikes, an energy crisis linked to the Iran war, ballooning US government debt, and i...
Metallus wins $995M contract to supply steel for U.S. Defense Logistics Agency over five years.
Metallus, a specialty metals producer, secured a five-year IDIQ contract with the U.S. Defense Logistics Agency valued up to $995 million to supply steel for critical defense uses. The contract includes an initial $125 million delivery order, with Me...
Anthropic plans $2T AI IPO amid soaring revenue but massive losses raise investor caution
Anthropic is preparing for an IPO with a record $2 trillion valuation, aiming to be the first pure AI company on the market. Despite a massive revenue surge of over 1,000% from 2024 to 2025, the company reported a $42 billion loss, including a $34 bi...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.